Status:
COMPLETED
Malglycemia in the Pediatric Hematopoietic Stem Cell Transplant Population
Lead Sponsor:
University of Colorado, Denver
Conditions:
Stem Cell Transplant Complications
Hyperglycemia
Eligibility:
All Genders
Up to 30 years
Brief Summary
This is a retrospective chart review of patients who underwent a hematopoietic stem cell transplant (HSCT) between 1994 and 2016 to evaluate incidence of malglycemia and the relationship to specific o...
Detailed Description
This is a retrospective chart review of patients who underwent a hematopoietic stem cell transplant between 2007 and 2016 to evaluate incidence and risk factors of malglycemia. The review will also ai...
Eligibility Criteria
Inclusion
- Age 0 to 30 years old at time of transplant
- Bone Marrow Transplant (BMT) recipient at Children's Hospital Colorado (CHCO) between 1/1/2007 and 7/31/2016
Exclusion
- Preexisting diabetes mellitus or known hyperglycemia
- Inadequate blood glucose data for analysis
Key Trial Info
Start Date :
September 6 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2019
Estimated Enrollment :
344 Patients enrolled
Trial Details
Trial ID
NCT03482154
Start Date
September 6 2016
End Date
June 30 2019
Last Update
September 30 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital Colorado
Aurora, Colorado, United States, 80045